Nrx Pharmaceuticals, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
NRx Pharmaceuticals has filed a registration statement for the resale of 3.3 million shares of common stock by selling stockholders, stemming from the conversion of debt and exercise of warrants.